170 related articles for article (PubMed ID: 23222714)
1. Role of OGR1 in myeloid-derived cells in prostate cancer.
Yan L; Singh LS; Zhang L; Xu Y
Oncogene; 2014 Jan; 33(2):157-64. PubMed ID: 23222714
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1.
Li H; Wang D; Singh LS; Berk M; Tan H; Zhao Z; Steinmetz R; Kirmani K; Wei G; Xu Y
PLoS One; 2009 May; 4(5):e5705. PubMed ID: 19479052
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
4. Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.
Shen L; Sundstedt A; Ciesielski M; Miles KM; Celander M; Adelaiye R; Orillion A; Ciamporcero E; Ramakrishnan S; Ellis L; Fenstermaker R; Abrams SI; Eriksson H; Leanderson T; Olsson A; Pili R
Cancer Immunol Res; 2015 Feb; 3(2):136-48. PubMed ID: 25370534
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Sinha P; Clements VK; Ostrand-Rosenberg S
Cancer Res; 2005 Dec; 65(24):11743-51. PubMed ID: 16357187
[TBL] [Abstract][Full Text] [Related]
6. Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.
Barakat DJ; Suresh R; Barberi T; Pienta KJ; Simons BW; Friedman AD
PLoS One; 2018; 13(1):e0191188. PubMed ID: 29324844
[TBL] [Abstract][Full Text] [Related]
7. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
8. NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma.
Suresh R; Barakat DJ; Barberi T; Zheng L; Jaffee E; Pienta KJ; Friedman AD
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940589
[TBL] [Abstract][Full Text] [Related]
9. Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.
Shafer-Weaver KA; Watkins SK; Anderson MJ; Draper LJ; Malyguine A; Alvord WG; Greenberg NM; Hurwitz AA
Cancer Res; 2009 Aug; 69(15):6256-64. PubMed ID: 19622771
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
Zhang Q; Yang X; Pins M; Javonovic B; Kuzel T; Kim SJ; Parijs LV; Greenberg NM; Liu V; Guo Y; Lee C
Cancer Res; 2005 Mar; 65(5):1761-9. PubMed ID: 15753372
[TBL] [Abstract][Full Text] [Related]
11. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance.
Kong X; Sun R; Chen Y; Wei H; Tian Z
J Immunol; 2014 Aug; 193(4):1645-53. PubMed ID: 25015833
[TBL] [Abstract][Full Text] [Related]
12. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
[TBL] [Abstract][Full Text] [Related]
13. Adoptive Transfer of Myeloid-Derived Suppressor Cells and T Cells in a Prostate Cancer Model.
Yan L; Xu Y
Bio Protoc; 2015 Aug; 5(16):. PubMed ID: 27441206
[TBL] [Abstract][Full Text] [Related]
14. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
[TBL] [Abstract][Full Text] [Related]
15. Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer.
Jenq RR; Curran MA; Goldberg GL; Liu C; Allison JP; van den Brink MR
PLoS One; 2012; 7(4):e35222. PubMed ID: 22493742
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68).
de Vallière C; Cosin-Roger J; Simmen S; Atrott K; Melhem H; Zeitz J; Madanchi M; Tcymbarevich I; Fried M; Kullak-Ublick GA; Vavricka SR; Misselwitz B; Seuwen K; Wagner CA; Eloranta JJ; Rogler G; Ruiz PA
Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):796-810. PubMed ID: 28174749
[TBL] [Abstract][Full Text] [Related]
17. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.
Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG
J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296
[TBL] [Abstract][Full Text] [Related]
18. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication.
Liu K; Jing N; Wang D; Xu P; Wang J; Chen X; Cheng C; Xin Z; He Y; Zhao H; Ji Z; Zhang P; Gao WQ; Zhu HH; Zhang K
Cell Prolif; 2021 Jul; 54(7):e13056. PubMed ID: 34021647
[TBL] [Abstract][Full Text] [Related]
19. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis.
Yang M; Mailhot G; Birnbaum MJ; MacKay CA; Mason-Savas A; Odgren PR
J Biol Chem; 2006 Aug; 281(33):23598-605. PubMed ID: 16787916
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of host Ogr1 enhances effector CD8
Cao L; Li W; Yang X; Zhang W; Li M; Zhang H; Qin C; Chen X; Gao R
Cancer Gene Ther; 2021 Nov; 28(10-11):1213-1224. PubMed ID: 34158625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
